Drug Development Time Is Five Years From Target To NDA, Glaxo's Sykes Says
Executive Summary
Glaxo SmithKline's development timeline from discovery of a novel target to NDA filing would be as little as five years, Glaxo Wellcome Chairman Richard Sykes maintained during a Jan. 18 briefing on the Glaxo SmithKline merger in New York City.